Treating Brain Swelling In Pediatric Cerebral Malaria

This long-standing research program focused on understanding and treating brain swelling in pediatric cerebral malaria. Building on more than a quarter century of work in Malawi and a landmark publication in the New England Journal of Medicine (2015), the collaborators identified a striking and lethal feature of pediatric cerebral malaria: massively swollen brains that herniate through the base of the skull, compress the brainstem, and precipitate respiratory arrest and death. This insight reframes fatal cerebral malaria as a problem of intracranial hypertension and mechanical compromise of respiratory control, rather than solely a systemic infectious process.

Supported by an $8.4 million grant from the National Institute of Allergy and Infectious Diseases (part of the NIH), Taylor's program aims to translate these pathophysiological findings into diagnostic, prognostic and therapeutic advances that can be applied in high-burden African settings. The research portfolio spans clinical imaging, bedside prediction, translational pathology, and interventional trials. Early systematic magnetic resonance imaging (MRI) studies conducted by Taylor and colleagues were central to visualizing brain swelling in affected children and establishing its association with fatal outcomes. Building on those MRI findings, associated work explores noninvasive measures of brain edema that can predict outcome in pediatric cerebral malaria, providing potential tools for triage and targeted intervention where MRI is not available.

Complementary studies described in the program examine related mechanisms, including parasite factors that adhere preferentially to brain endothelium, parasite-derived histones that promote blood-brain barrier breakdown and coagulopathy, and immune cell (CD8+ T cell) accumulation in the cerebrovasculature, all contributing to a multifactorial picture of cerebral injury and edema.

The research agenda also includes efforts to identify children at greatest risk of progression to cerebral malaria, with the goal of earlier intervention, and clinical studies exploring adjunctive therapies (for example, dose-finding studies such as pentoxifylline) that might mitigate damaging host responses or cerebral edema. Taylor's work emphasizes contextualized, pragmatic approaches appropriate for high-burden African hospitals where children between one and three years old are especially affected. Through imaging, bedside assessment tools, mechanistic pathology and interventional studies, the program seeks to move from descriptive discovery to implementable strategies that prevent brain herniation and respiratory arrest, ultimately reducing the mortality and long-term disability of pediatric cerebral malaria.